Skip to content

E-health Care Process Support for Diabetes Type II Patients

E-support for Healthcare Processes - DIABETES

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01566981
Acronym
EHDI
Enrollment
120
Registered
2012-03-30
Start date
2012-03-31
Completion date
2014-02-28
Last updated
2014-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus Type II,

Keywords

Diabetes mellitus tip II, eHealth solution, Health Information Technology, quality of life, family medicine, satisfaction with e-health care, primary care

Brief summary

The purpose of the study is to clinically evaluate a new approach to treatment of patients with diabetes mellitus type II by using specially developed mobile-internet software solution. The effect of information and communication technologies (ICT) to improve the integrated care of people with diabetes will be identified, developed, introduced and clinically evaluated. The investigators expect that usage of an e-Health application in health care of patients with diabetes mellitus type II could improve the following healthcare outcomes: results of the laboratory tests (with emphasis on HbA1C value), regular medication usage, blood pressure values, Body mass index (BMI) values, diet, regular exercise and quality of life.

Detailed description

Diabetes mellitus (DM) is defined as a group of common metabolic disorders that share the phenotype of hyperglycemia. It is generally agreed that in Caucasian populations the prevalence rate is between 2% and 6%. Prevalence rate of DM in SLovenia is about 5%. Type 2 DM accounts for 90% to 95% of all diabetes cases. Results of many clinical studies demonstrated the great potential of information and communication technology (ICT) applications to improve health care of patients with chronic diseases including diabetes mellitus. In this study an ICT mobile environment to improve the process of an integrated care of people with Diabetes mellitus will be identified, developed, introduced and clinically evaluated. The study will include 140 patients diagnosed with diabetes mellitus type II who are managed in primary care. The study will use and evaluation questionnaire that will cover issues regarding the patient quality of life. Subjects with a blood pressure meter and a scale, will be able to enter the value of the systolic and diastolic blood pressure and the body weight. Subjects will be motivated to regularly enter data about their blood pressure, body weight, dietary misconducts and to complete available questioners. In addition to this, users can enter values about their physical activity (type, duration, intensity).

Interventions

PROCEDUREComputerised support to the Diabetes type II patients

The randomly selected group of patients with diabetes type II will get software application and web based support to their usual healthcare process.

Sponsors

University of Ljubljana School of Medicine, Slovenia
CollaboratorOTHER
University of Primorska
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Type 2 diabetes, treated with non-pharmacological interventions or/and tablets (Non-Insulin-Dependent Diabetes Mellitus) * Internet connection and personal computer /lap-top computer * Mobile phone * Sufficient level of Internet and e-mail usage - checked by short questionnaire * Age \>18 or \<75 years

Exclusion criteria

* significant co-morbidity * Type 1 diabetes * Insulin-dependent type 2 diabetes

Design outcomes

Primary

MeasureTime frame
Change From Baseline in HbA1C at 1 Year.1 year

Secondary

MeasureTime frameDescription
Patients' Functional Health Status Via WONCA-COOP Questionnaire.one yearWONCA COOP questionnaire measure seven core aspects of functional status, therefore this instrument consists of 7 five-point ordinal sub-scales. Each scale ranging from 1 ('no limitation at all') to 5 ('severely limited'); for 'change in health' score 1 means 'much better' and score 5'much worse'. Sub-scales are averaged to compute a total score.
Change of Blood Lipid Level ( Low Density Cholesterol)baseline and one year
Body Mass Index at 1 Yearone year
Change of Patients' Functional Health Status Via WONCA-COOP Questionnaire.baseline and one year
Change of the Following Parameter : HbA1Cbaseline and six months
Quality of Patients' Life Via WONCA-COOP Questionnaire.baseline and one year

Countries

Slovenia

Participant flow

Participants by arm

ArmCount
Diabetes With ICT Support (E-diabetes)
The group of randomly selected patients with Diabetes mellitus (DM) type II, who will get the software application and web- based support Intervention: Computerized support to the Diabetes type II patients Computerized support to the Diabetes type II patients: The randomly selected group of patients with diabetes type II will get software application and web based support to their usual healthcare process.
58
Diabetes Without Support
The group of randomly selected patients with DM type II, without software application and web-based support.
62
Total120

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up58

Baseline characteristics

CharacteristicDiabetes With ICT Support (E-diabetes)Diabetes Without SupportTotal
Age, Continuous56.3 years
STANDARD_DEVIATION 10.5
54.7 years
STANDARD_DEVIATION 11.1
55.5 years
STANDARD_DEVIATION 10.7
Sex: Female, Male
Female
22 Participants25 Participants47 Participants
Sex: Female, Male
Male
36 Participants37 Participants73 Participants
Years of DM treatment5.1 years
STANDARD_DEVIATION 5.7
5.7 years
STANDARD_DEVIATION 4.8
5.5 years
STANDARD_DEVIATION 5.3

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 580 / 62
serious
Total, serious adverse events
0 / 580 / 62

Outcome results

Primary

Change From Baseline in HbA1C at 1 Year.

Time frame: 1 year

ArmMeasureValue (MEAN)Dispersion
Diabetes With ICT Support (E-diabetes)Change From Baseline in HbA1C at 1 Year.0.6925 percentage of glycated haemoglobinStandard Deviation 1.4708
Diabetes Without SupportChange From Baseline in HbA1C at 1 Year.0.1707 percentage of glycated haemoglobinStandard Deviation 1.0617
Comparison: Null hypothesis was that Information and Communication Technology (ICT) supported diabetes care could have significant impact on reduction of baseline glycated hemoglobin (EHbA1c) after 1 year follow-up.~The sample in intervention group was normally distributed, so observed power (two-tailed hypothesis) was 0.45, for Cohen's d= 0.6 and alpha level =0.05p-value: 0.00595% CI: [0.2221, 1.1629]t-test, 2 sided
Secondary

Body Mass Index at 1 Year

Time frame: one year

ArmMeasureValue (MEAN)Dispersion
Diabetes With ICT Support (E-diabetes)Body Mass Index at 1 Year31.76 Kg/m2Standard Deviation 4.87
Diabetes Without SupportBody Mass Index at 1 Year32.6 Kg/m2Standard Deviation 5.14
Secondary

Change of Blood Lipid Level ( Low Density Cholesterol)

Time frame: baseline and one year

Secondary

Change of Blood Lipid Level ( Low Density Cholesterol)

Time frame: baseline and six months

Secondary

Change of Patients' Functional Health Status Via WONCA-COOP Questionnaire.

Time frame: baseline and one year

Secondary

Change of the Following Parameter : HbA1C

Time frame: baseline and six months

Secondary

Patients' Functional Health Status Via WONCA-COOP Questionnaire.

WONCA COOP questionnaire measure seven core aspects of functional status, therefore this instrument consists of 7 five-point ordinal sub-scales. Each scale ranging from 1 ('no limitation at all') to 5 ('severely limited'); for 'change in health' score 1 means 'much better' and score 5'much worse'. Sub-scales are averaged to compute a total score.

Time frame: one year

ArmMeasureValue (MEAN)Dispersion
Diabetes With ICT Support (E-diabetes)Patients' Functional Health Status Via WONCA-COOP Questionnaire.2.12 units on a scaleStandard Deviation 0.66
Diabetes Without SupportPatients' Functional Health Status Via WONCA-COOP Questionnaire.1.89 units on a scaleStandard Deviation 0.58
Secondary

Quality of Patients' Life Via WONCA-COOP Questionnaire.

Time frame: baseline and one year

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026